MCID: APR001
MIFTS: 40

Apraxia malady

Rare diseases, Fetal diseases categories

Aliases & Classifications for Apraxia

About this section

Summaries for Apraxia

About this section
NINDS:46 Apraxia (called "dyspraxia" if mild) is a neurological disorder characterized by loss of the ability to execute or carry out skilled movements and gestures, despite having the desire and the physical ability to perform them. Apraxia results from dysfunction of the cerebral hemispheres of the brain, especially the parietal lobe, and can arise from many diseases or damage to the brain.There are several kinds of apraxia, which may occur alone or together. The most common is buccofacial or orofacial apraxia, which causes the inability to carry out facial movements on command such as licking lips, whistling, coughing, or winking. Other types of apraxia include limb-kinetic apraxia (the inability to make fine, precise movements with an arm or leg), ideomotor apraxia (the inability to make the proper movement in response to a verbal command), ideational apraxia (the inability to coordinate activities with multiple, sequential movements, such as dressing, eating, and bathing), verbal apraxia (difficulty coordinating mouth and speech movements), constructional apraxia (the inability to copy, draw, or construct simple figures), and oculomotor apraxia (difficulty moving the eyes on command). Apraxia may be accompanied by a language disorder called aphasia. Corticobasal ganglionic degeneration is a disease that causes a variety of types of apraxia, especially in elderly adults.

MalaCards based summary: Apraxia, also known as apraxias, is related to ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia and spinocerebellar ataxia, autosomal recessive 1. An important gene associated with Apraxia is APTX (Aprataxin), and among its related pathways is Organelle biogenesis and maintenance. Affiliated tissues include brain, testes and cortex, and related mouse phenotypes are vision/eye and cellular.

Disease Ontology:10 An agnosia that is a loss of the ability to map out physical actions in order to repeat them in functional activities.

Wikipedia:68 Apraxia is a motor disorder caused by damage to the brain (specifically the posterior parietal cortex),... more...

Related Diseases for Apraxia

About this section

Diseases related to Apraxia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 249)
idRelated DiseaseScoreTop Affiliating Genes
1ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia31.2APTX, PIK3R5, PNKP, SETX
2spinocerebellar ataxia, autosomal recessive 130.6AFP, APTX, PIK3R5, SETX
3joubert syndrome with renal anomalies29.7CC2D2A, INPP5E, TMEM216, TMEM231
4joubert syndrome 129.4AHI1, C5orf42, CC2D2A, INPP5E, NPHP1, TMEM216
5ataxia10.8
6ideomotor apraxia10.8
7childhood apraxia of speech10.8
8aphasia10.8
9corticobasal degeneration10.6
10gait apraxia10.6
11agnosia10.5
12dementia10.5
13blepharospasm10.4
14ataxia-oculomotor apraxia 310.4
15cerebritis10.4
16oculomotor apraxia cogan type10.4
17developmental dyspraxia10.4
18ataxia-oculomotor apraxia 410.3
19primary progressive apraxia of speech10.3
20wieacker-wolff syndrome10.3
21developmental coordination disorder10.3
22stroke, ischemic10.3
23speech disorder10.3
24cerebellar ataxia10.3
25speech and communication disorders10.3
26rolandic epilepsy - speech dyspraxia10.2
27alzheimer disease10.2
28hydrocephalus10.2
29neuronitis10.2
30ataxia-telangiectasia10.2
31gaucher's disease10.2
32developmental dysphasia familial10.2
33ocular motor apraxia, cogan type10.2
34autosomal dominant nocturnal frontal lobe epilepsy10.2APTX, SETX
35alcohol-induced mental disorder10.2APTX, SETX
36multiple system atrophy10.1
37joubert syndrome 1510.1
38joubert syndrome 2110.1
39joubert syndrome 610.1
40joubert syndrome 1610.1
41joubert syndrome 210.1
42alzheimer disease, type 310.1
43ataxia, spastic, 5, autosomal recessive10.1
44nasu-hakola disease10.1
45normal pressure hydrocephalus10.1
46mutism10.1
47articulation disorder10.1
48cerebrovascular disease10.1
49neurologic diseases10.1
50encephalopathy10.1

Graphical network of the top 20 diseases related to Apraxia:



Diseases related to apraxia

Symptoms for Apraxia

About this section

Drugs & Therapeutics for Apraxia

About this section

Drugs for Apraxia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 14)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1Botulinum ToxinsPhase 4590
2Botulinum Toxins, Type APhase 4561
3
GlycerolexperimentalPhase 317656-81-5753
Synonyms:
1,2,3-Trihydroxypropane
Bulbold
Cristal
E 422
Emery 916
Glyceol Opthalgan
Glycerin
Glycerine
Glyceritol
Glycerol
 
Glycyl alcohol
Glyrol
Glysanin
IFP
Incorporation factor
Mackstat H 66
Osmoglyn
Pricerine 9091
Propanetriol
RG-S
Trihydroxypropane
Tryhydroxypropane
4Phase 3
5UbiquinonePhase 390
6Complement System ProteinsPhase 3171
7LecithinNutraceuticalPhase 357
8
Coenzyme Q10NutraceuticalPhase 3101303-98-05281915
Synonyms:
(all-E)-2,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31-octamethyl-2,6,10,14,18,22,26,30-dotriacontaoctaenyl)-2,5-Cyclohexadiene-1,4-dione
(all-E)-2-(3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-2,5-Cyclohexadiene-1,4-dione
2-(3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-p-Benzoquinone
2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl]-5,6-dimethoxy-3-methyl- 2,5-Cyclohexadiene-1,4-dione
4-Ethyl-5-fluoropyrimidine
Aqua Q 10L10
Aqua Q10
Bio-Quinon
Bio-Quinone Q10
CoQ10
Coenzyme Q10
Ensorb
Kaneka Q10
Kudesan
 
Li-Q-Sorb
Liquid-Q
Neuquinon
Neuquinone
PureSorb Q 40
Q 10AA
Q-Gel
Q-Gel 100
Ubidecarenone
Ubiquinone 10
Ubiquinone 50
Ubiquinone Q10
Ubiquinone-10
Unbiquinone
Unispheres Q 10
9
Memantineapproved, investigationalPhase 216819982-08-24054
Synonyms:
1,3-Dimethyl-5-adamantanamine
1-Amino-3,5-dimethyladamantane
19982-08-2
3,5-Dimethyl-1-adamantanamine
3,5-Dimethyl-1-adamantylamine
3,5-Dimethyl-1-aminoadamantane
3,5-Dimethyladamantan-1-ylamine
3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine
3,5-dimethyladamantan-1-amine
3,5-dimethyltricyclo[3.3.1.1~3,7~]decan-1-amine
41100-52-1 (Hydrochloride)
51052-62-1
AB00053600
AC1L1HB7
AKOS000113995
BBL000737
BPBio1_001117
BPBio1_001270
BSPBio_001015
Biomol-NT_000209
C13736
CBMicro_020348
CHEBI:152523
CHEMBL807
CID4054
D08174
DB01043
DMAA
DivK1c_000068
EU-0053634
Ebixa
Exiba
Exiba (TN)
HMS500D10
HSDB 7327
IDI1_000068
KBio1_000068
KBio2_001087
KBio2_003655
 
KBio2_006223
KBio3_001926
KBioGR_001543
KBioSS_001087
LS-157051
Lopac0_000861
Memantin
Memantina
Memantina [INN-Spanish]
Memantine
Memantine (INN)
Memantine HCL
Memantine Hydrochloride
Memantine [INN:BAN]
Memantine [INN]
Memantinum
Memantinum [INN-Latin]
MolPort-002-041-858
NCGC00015705-05
NCGC00024782-02
NCGC00024782-03
NINDS_000068
Namenda
Oprea1_480562
Prestwick0_000978
Prestwick1_000978
Prestwick2_000978
Prestwick3_000978
SPBio_001456
SPBio_002926
ST057652
STK520682
Spectrum2_001408
Spectrum3_000923
Spectrum4_001022
Spectrum5_001355
Spectrum_000607
UNII-W8O17SJF3T
ZERO/006024
memantine
10
DopamineapprovedPhase 2281462-31-7, 51-61-6681
Synonyms:
(3H)-Dopamine
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-Dihydroxyphenyl)ethylamine
2-(3,4-dihydroxyphenyl)ethylamine
2-benzenediol
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3,4-dihydroxyphenethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)-Pyrocatechol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
4-(2-aminoethyl)-pyrocatechol
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
ASL 279
BIDD:ER0506
BPBio1_001123
BSPBio_001932
Biomol-NT_000001
C03758
CHEBI:18243
CHEMBL59
CID681
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine Hcl
Dopamine Hydrochloride
Dopamine [INN:BAN]
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydroxytyramin
Hydroxytyramine
IDI1_000780
IP 498
Intropin
Intropin [*hydrochloride*]
 
KBio1_000780
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L-DOPAMINE
L000232
LDP
LS-159
Lopac-H-8502
Lopac0_000586
Medopa (TN)
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
SPECTRUM1505155
ST048774
STK301601
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
Spectrum_001012
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
cMAP_000036
cMAP_000065
dopamine
hydroxytyramine
intropin
m-Hydroxytyramine hydrochloride
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
11Fluorodeoxyglucose F18Phase 1340
12
CorticosteronePhase 1950-22-65753
Synonyms:
11,21-Dihydroxypregn-4-ene-3,20-dione
11,21-Dihydroxyprogesterone
11-Hydroxycorticoaldosterone
 
17-Deoxycortisol
4-Pregnene-11 Corticosteron
Corticosterone
Kendall'S compound B
Reichstein'S substance H
13DeoxyglucosePhase 194
14vitamin d1463

Interventional clinical trials:

(show all 37)
idNameStatusNCT IDPhase
1The Use of Botox in Advanced Parkinson's Patients Experiencing PainActive, not recruitingNCT02472210Phase 4
2Tolvaptan to Reduce Length of Stay in Hospitalized Patients With Cirrhosis and HyponatremiaTerminatedNCT01890694Phase 4
3Evolution of Albumin on AOA1 Patients Supplemented With Coenzyme Q10Active, not recruitingNCT02333305Phase 3
4Electrical Polarization of the Brain in Corticobasal SyndromeCompletedNCT00273897Phase 2
5Treatment Intensity - Apraxia of SpeechRecruitingNCT02332915Phase 2
6Evaluating Anodal tDCS Preceding Aphasia TherapyRecruitingNCT02249819Phase 1, Phase 2
7A Multi-site Double-blind Placebo-controlled Trial of Memantine Versus Placebo in Children With Autism (MEM)Active, not recruitingNCT01372449Phase 2
8A Safety and Tolerability Study of JNJ-54861911 in Participants With Early Alzheimer's DiseaseActive, not recruitingNCT02260674Phase 2
9PiB PET Scanning in Speech and Language Based DementiasCompletedNCT01623284Phase 1
10A Novel Treatment for Aphasia and Apraxia of Speech : Measurement of OutcomesRecruitingNCT01979159Phase 1
11Treatments of Acquired Apraxia of SpeechActive, not recruitingNCT01483807Phase 1
12Apraxia of Speech: Comparison of EPG Treatment (Tx) and Sound Production Treatment (SPT)Not yet recruitingNCT02554513Phase 1
13EEG and EMG Analysis of Ideomotor ApraxiaCompletedNCT00024999
14Occupational Therapy in Patients With Multiple SclerosisCompletedNCT01507636
15Stuttering and Apraxia of Speech: the Efficacy of an Intervention ProgramCompletedNCT01097161
16Using fMRI to Understand the Roles of Brain Areas for Fine Hand MovementsCompletedNCT00063115
17Clinical Findings in General ParesisCompletedNCT00921648
18Orientation Agnosia: Clinical and Anatomical StudyCompletedNCT01304576
19Central Mechanisms in Speech Motor Control Studied With H215O PETCompletedNCT00001308
20Functional Rehabilitation of Upper Limb Apraxia in Patients PoststrokeRecruitingNCT02199093
21Longitudinal Multi-Modality Imaging in Progressive Apraxia of SpeechRecruitingNCT01818661
22Auditory Masking Effects on Speech Fluency in Aphasia and Apraxia of SpeechRecruitingNCT02094014
23Intervention on Caregivers Caring for Patients Poststroke With Upper Limb ApraxiaRecruitingNCT02307019
24Construction-LBD (Constructional Apraxia in Alzheimer's Disease (AD) and Lewy Body's Dementia (LBD))RecruitingNCT01993628
25Action Observation Treatment (AOT) as a Rehabilitation ToolRecruitingNCT02235350
26Brain Biomarkers of Response to Treatment for Apraxia of SpeechRecruitingNCT02046941
27Gait and Alzheimer Interaction Tracking (GAIT) StudyRecruitingNCT01315717
28Alzheimer's Disease and Related DisordersRecruitingNCT01315704
29Study of Adherence and Effects of Balance Exercices (SIEL BLEU Associatio)RecruitingNCT01314638
30Rehabilitation Combined With Bihemispherictranscranial Direct Current Stimulation in Subacute Ischemic StrokeRecruitingNCT01644929
31Transcranial and Rapid Magnetic Stimulation for Gait Apraxia Due to Normal Pressure Hydrocephalus and Cerebral IschemiaRecruitingNCT00494689
32Clinical and Molecular Investigations Into CiliopathiesRecruitingNCT00068224
33Exploring the Impact and Feasibility of a Pathway to Sport and Long-term Participation in Young PeopleRecruitingNCT02517333
34Deep Brain Stimulation for Patients With Dementia With Lewy BodiesRecruitingNCT02263937
35Cognitive Assessment for Stroke Patients: Reproductibility and Validity StudyRecruitingNCT01904799
36Scholar Performance and Praxis Assessment in Children With Rolandic EpilepsyActive, not recruitingNCT01046760
37Upper Limbs Intervention in Multiple SclerosisActive, not recruitingNCT02047825

Search NIH Clinical Center for Apraxia

Genetic Tests for Apraxia

About this section

Anatomical Context for Apraxia

About this section

MalaCards organs/tissues related to Apraxia:

33
Brain, Testes, Cortex, Parietal lobe, Eye, Subthalamic nucleus, Occipital lobe

Animal Models for Apraxia or affiliated genes

About this section

MGI Mouse Phenotypes related to Apraxia:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053917.6AHI1, CC2D2A, INPP5E, MAPT, NPHP1, TMEM231
2MP:00053846.9AFG3L2, AHI1, APTX, ATM, CC2D2A, INPP5E

Publications for Apraxia

About this section

Articles related to Apraxia:

(show top 50)    (show all 665)
idTitleAuthorsYear
1
Volubility, consonant, and syllable characteristics in infants and toddlers later diagnosed with childhood apraxia of speech: A pilot study. (25934424)
2015
2
A new model to study neurodegeneration in ataxia oculomotor apraxia type 2. (26231220)
2015
3
Oral Articulatory Control in Childhood Apraxia of Speech. (25951237)
2015
4
Right lower limb apraxia in a patient with left supplementary motor area infarction: intactness of the corticospinal tract confirmed by transcranial magnetic stimulation. (25883636)
2015
5
Ataxia with oculomotor apraxia type 2: not always an easy diagnosis. (25787807)
2015
6
A case of pathology-proven neuromyelitis optica spectrum disorder with SjAPgren syndrome manifesting aphasia and apraxia due to a localized cerebral white matter lesion. (24986696)
2014
7
Assistive system for people with Apraxia using a Markov decision process. (25160274)
2014
8
Ultrasound biofeedback treatment for persisting childhood apraxia of speech. (23813207)
2013
9
Primary progressive apraxia: a syndrome difficult to categorize. (23588293)
2013
10
Novel SETX variants in a patient with ataxia, neuropathy, and oculomotor apraxia are associated with normal sensitivity to oxidative DNA damaging agents. (24183476)
2013
11
Differential diagnosis between apraxia and dysarthria based on acoustic analysis. (22774423)
2012
12
Non-verbal communication in severe aphasia: influence of aphasia, apraxia, or semantic processing? (21458789)
2012
13
Ataxia with oculomotor apraxia type1 (AOA1): novel and recurrent aprataxin mutations, coenzyme Q10 analyses, and clinical findings in Italian patients. (21465257)
2011
14
Computer-Mediated Assessment of Intelligibility in Aphasia and Apraxia of Speech. (22215933)
2011
15
Pure apraxia of speech - a case report -. (22506197)
2011
16
The importance of production frequency in therapy for childhood apraxia of speech. (21330650)
2011
17
Sensory neuronopathy in ataxia with oculomotor apraxia type 2. (20869730)
2010
18
Early-onset ataxia with ocular motor apraxia and hypoalbuminemia/ataxia with oculomotor apraxia 1. (20687492)
2010
19
Apraxia. (22810515)
2010
20
Ataxia with oculomotor apraxia type 2: a clinical and genetic study of 19 patients. (19141356)
2009
21
Ataxia oculomotor apraxia type 2: course over 27 years and a novel stop mutation in the senataxin gene. (19377860)
2009
22
Scanning your body is different from performing body movements: a double dissociation between body representational neglect and apraxia. (19084546)
2009
23
A model-based approach to understanding apraxia in Corticobasal Syndrome. (19082735)
2009
24
Acquired apraxia of speech: a review. (19008207)
2008
25
Nigrostriatal involvement in ataxia with oculomotor apraxia type 1. (18004640)
2008
26
Eyelid opening apraxia in an AIDS patient. (18067181)
2008
27
Visuomotor tracking abilities of speakers with apraxia of speech or conduction aphasia. (18558428)
2008
28
Cognitive approach to the assessment of limb apraxia. (17853141)
2008
29
The sound of actions in apraxia. (19013068)
2008
30
Consonant and syllable structure patterns in childhood apraxia of speech: developmental change in three children. (16469328)
2006
31
Interactions between volitional and automatic breathing during respiratory apraxia. (16185939)
2006
32
Clinical and anatomical correlates of apraxia of speech. (16516956)
2006
33
New autosomal recessive cerebellar ataxias with oculomotor apraxia. (16131425)
2005
34
Improvement of apraxia of lid opening by STN-stimulation in a 70-year-old patient with Parkinson's disease. A case report. (15100935)
2004
35
Defective pantomime of object use in left brain damage: apraxia or asymbolia? (12887981)
2003
36
Cognitive representations of hand posture in ideomotor apraxia. (12667544)
2003
37
Limb-kinetic apraxia in corticobasal degeneration: clinical and kinematic features. (12518300)
2003
38
Apraxia of eyelid opening secondary to a dominant hemispheric infarction. (11993536)
2002
39
Cortical and subcortical contributions to ideomotor apraxia: analysis of task demands and error types. (11701604)
2001
40
The use of a digital voice output device to facilitate language development in a child with developmental apraxia of speech: a case study. (11697460)
2001
41
Combined semantic dementia and apraxia in a patient with frontotemporal lobar degeneration. (11090722)
2000
42
Ptosis, blepharospasm, and apraxia of eyelid opening secondary to putaminal hemorrhage. (10449142)
1999
43
Ataxia-oculomotor apraxia syndrome. (7782601)
1995
44
Ataxia with Oculomotor Apraxia Type 1 (20301629)
1993
45
Ideomotor apraxia: evidence for the preservation of axial commands. (2454297)
1988
46
Axial movements in ideomotor apraxia. (6186771)
1982
47
Gait apraxia in communicating hydrocephalus. (7241157)
1981
48
Intracranial calcification in hyperparathyroidism associated with gait apraxia and parkinsonism. (7191528)
1980
49
Clumsy children: developmental apraxia and agnosia. (13998739)
1962
50
Aphasia, apraxia, and agnosia; a new classification. (21017997)
1946

Variations for Apraxia

About this section

Expression for genes affiliated with Apraxia

About this section
Search GEO for disease gene expression data for Apraxia.

Pathways for genes affiliated with Apraxia

About this section

Pathways related to Apraxia according to GeneCards Suite gene sharing:

idSuper pathways (with members indented)ScoreTop Affiliating Genes
1
Show member pathways
8.7CC2D2A, INPP5E, NPHP1, TMEM216

GO Terms for genes affiliated with Apraxia

About this section

Cellular components related to Apraxia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1chromosome, telomeric regionGO:000078110.1ATM, SETX
2ciliumGO:00059299.4AHI1, NPHP1, TMEM216
3ciliary transition zoneGO:00358699.2CC2D2A, NPHP1, TMEM216, TMEM231
4TCTN-B9D complexGO:00360389.0AHI1, CC2D2A, TMEM216, TMEM231
5cytoskeletonGO:00058568.7CC2D2A, INPP5E, NPHP1, TMEM216

Biological processes related to Apraxia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1polynucleotide 3 dephosphorylationGO:009850610.4APTX, PNKP
2double-strand break repairGO:00063029.7APTX, ATM, SETX
3cilium morphogenesisGO:00602719.3AHI1, CC2D2A, TMEM216
4organelle organizationGO:00069968.4CC2D2A, INPP5E, NPHP1, TMEM216
5cilium assemblyGO:00423848.2AHI1, C5orf42, CC2D2A, TMEM216, TMEM231

Molecular functions related to Apraxia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1polynucleotide 3-phosphatase activityGO:004640310.0APTX, PNKP

Sources for Apraxia

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet